Is Corcept Therapeutics a good buy right now?
USNASDAQ: CORTNASDAQ-listedlast $110 · 30 Jul 2026
Not yet — wait
Signal paused. CORT's price history has a jump — most likely a split or bonus issue that was not adjusted — and 2 trades touching it were left out until the data is checked. The last Buy signal came on 28 May 2026 at $69.85 and closed on 30 Jul 2026 (+57.5%).
As of 30 Sep 2026 · Firefly Breakout Weekly
What happened after the last 5 buy signals on CORT
Oct 2024 – 30 Sep 20262 of 5 closed above the entry price, with an average outcome of +15.0% per signal before costs; a signal typically stayed open about 4 wk. 2 trades touching a jump in the price data were left out.
| Buy signal | Price then | Closed | Held | Outcome |
|---|---|---|---|---|
| 28 May 2026 | $69.85 | 30 Jul 2026 | 9 wk | +57.5% |
| 18 Sep 2025 | $79.91 | 13 Oct 2025 | 4 wk | -11.4% |
| 2 Apr 2025 | $89.61 | 3 Apr 2025 | 1 d | -13.5% |
| 12 Feb 2025 | $70.59 | 21 Feb 2025 | 9 d | -10.4% |
| 1 Oct 2024 | $46.16 | 30 Jan 2025 | 4 mo | +52.8% |
Outcomes are simulated by applying Firefly's rules to historical prices, before costs and slippage. Sell triggers are not counted: Firefly reads them as “don't enter”, not as short trades. Past behaviour of a rule is not a prediction of future prices.
The strategy behind this page
one rule set per market · beta| Strategy | Horizon | Signal | Since | Buy signals closed higher |
|---|---|---|---|---|
| Firefly Breakout Weekly | Medium term | No signal | — | 40% |
This beta publishes one rule set per market — Firefly Breakout Weekly — chosen in the October 2026 review. What the beta shows and how the data was cleaned →
Same theme beyond US
same theme, other marketsIndian peers are listed on the NSE and priced in rupees. Crypto gains are taxed at 30% in India with 1% TDS. Shown for context — not a recommendation to switch markets.
More questions about CORT
CORT share price today — buy or sell?
As of 30 Sep 2026, Firefly Breakout Weekly says wait on Corcept Therapeutics. Signal paused. CORT's price history has a jump — most likely a split or bonus issue that was not adjusted — and 2 trades touching it were left out until the data is checked. The last Buy signal came on 28 May 2026 at $69.85 and closed on 30 Jul 2026 (+57.5%). The last price on record was $110 on 30 Jul 2026.
How has Firefly's strategy done on Corcept Therapeutics?
From October 2024 to 30 Sep 2026 Firefly's rules gave 5 buy signals on Corcept Therapeutics; 2 closed above the entry price and the average outcome was +15.0% per signal, simulated on historical prices before costs. A handful of signals is a pattern, not a statistic.
What is the Corcept Therapeutics price target?
We don't publish price targets — no rule-based system can forecast a price. Firefly Breakout Weekly closes each signal by its own rules; every closed signal on Corcept Therapeutics and how it turned out is listed on this page.
Should I sell Corcept Therapeutics?
No sell trigger is active on Corcept Therapeutics as of 30 Sep 2026. This describes a rule, not advice on your position.
Why does this page show a single strategy?
This is the Signals beta. Each market publishes one rule set — here Firefly Breakout Weekly — instead of a vote across Firefly's whole library, and the verdict is its signal as of 30 Sep 2026. Sell triggers count as “don't enter”; only buy triggers are scored.
Fintrens shows how one of Firefly's rule-based strategies reads this stock. It is educational information, not investment advice and not a recommendation to buy or sell. We do not publish price targets. Indian residents buy US stocks under the RBI's Liberalised Remittance Scheme; tax is collected at source above the annual threshold. Read how Firefly's strategies work →